cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2017.10.10043cardio-42Research ArticleПРАКТИЧЕСКАЯ КАРДИОЛОГИЯ ПРИЛОЖЕНИЕ ДЛЯ ПРАКТИЧЕСКИХ ВРАЧЕЙ. КЛИНИЧЕСКИЕ СЕМИНАРЫPRACTICAL CARDIOLOGY SUPPLEMENT FOR PRACTISING PHYSICIANS. CLINICAL SEMINARSПриверженность к лечению пожилых больных с хронической сердечной недостаточностьюMedication Adherence of Elderly Patients With Chronic Heart FailureЧукаеваИ. Н.ChukaevaI. I.noemail@neicon.ruЛаринаВ. Н.LarinaVera N.larinav@mail.ruКарпенкоД. Г.KarpenkoD. G.noemail@neicon.ruПоздняковаА. В.PozdnyakovaA. V.noemail@neicon.ruГБОУВПО «Российский национальный исследовательский медицинский университет им. Н. И. Пирогова» Минздрава РФРоссияThe Russian National Research Medical University named after N. I. PirogovRussian FederationГБОУ ВПО «Московский государственный университет имени М. В. Ломоносова»РоссияLomonosov Moscow State UniversityRussian Federation20171711201857106572Copyright © Kardiomag, 20182018KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/42

Обзор посвящен проблеме приверженности к лечению пожилых больных с хронической сердечной недостаточностью (ХСН). Обсуждаются особенности подхода к ведению лиц пожилого возраста в амбулаторных условиях, группы факторов, ассоциируемых с приверженностью к лечению, а также возможные пути ее повышения у лиц старшей возрастной группы с ХСН.

Le review is devoted to the problem of medication adherence in elderly patients with chronic heart failure. We consider here specificity of approach to management of elderly outpatients, groups of factors associated with medication adherence, and possible ways to improvement of compliance to treatment in patients from the senior age group with heart failure.

хроническая сердечная недостаточностьприверженность к лечениюкомплаенспожилой возрастheart failuremedication adherencetreatment complianceelderly agepatientsReferencesLainscak M., Cleland J., Lenzen M. Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. Am J Cardiol 2007;99 (6B): 31-37Lainscak M., Cleland J., Lenzen M. Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. Am J Cardiol 2007;99 (6B): 31-37van der Wal M., van Veldhuisen D., Veeger N. et al. Compliance with non-pharmacological recommendations and outcome in heart failure patients. Eur Heart J 2010;31 (12):1486-1493van der Wal M., van Veldhuisen D., Veeger N. et al. Compliance with non-pharmacological recommendations and outcome in heart failure patients. Eur Heart J 2010;31 (12):1486-1493Pazos-Lopez P., Peteiro-Vazquez J., Carcia-Campos A. et al. The causes, consequences, and treatment of left or right heart failure. Vascular Health and Risk Management 2011;7:237-254.Pazos-Lopez P., Peteiro-Vazquez J., Carcia-Campos A. et al. The causes, consequences, and treatment of left or right heart failure. Vascular Health and Risk Management 2011;7:237-254.Muzzarelli S., Rocca H., Pfister O. et al. Adherence to the medical regime in patients with heart failure. Eur J. Heart Fail 2010; 12: 389-396.Muzzarelli S., Rocca H., Pfister O. et al. Adherence to the medical regime in patients with heart failure. Eur J. Heart Fail 2010; 12: 389-396.Gjesing A., Schou M., Torp-Pedersen C. et al. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur J. Heart Fail 2013;15 (6):671-678.Gjesing A., Schou M., Torp-Pedersen C. et al. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur J. Heart Fail 2013;15 (6):671-678.Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization 2003;211 p. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf.Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization 2003;211 p. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf.Ефремова Е. В., Мевзоров М. В., Сабитов И. А. Приверженность к лечению больных с хронической сердечной недостаточностью в условиях коморбидности. Клиническая медицина 2015;10:20-24Ефремова Е. В., Мевзоров М. В., Сабитов И. А. Приверженность к лечению больных с хронической сердечной недостаточностью в условиях коморбидности. Клиническая медицина 2015;10:20-24Ларина В. Н., Барт Б. Я., Головко М. Г. и др. Факторы, негативно влияющие на течение и прогноз хронической сердечной недостаточности в пожилом возрасте. Вестник РГМУ 2012;5:10-14Ларина В. Н., Барт Б. Я., Головко М. Г. и др. Факторы, негативно влияющие на течение и прогноз хронической сердечной недостаточности в пожилом возрасте. Вестник РГМУ 2012;5:10-14Yancy C., Fonarow G., Albert N. et al. Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF). Am J. Cardiol 2010;105:255-260.Yancy C., Fonarow G., Albert N. et al. Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF). Am J. Cardiol 2010;105:255-260.McMurray J., Pfeffer M. Review of the current state of the art in heart failure. Heart failure. Lancet 2005;365:1877-1889.McMurray J., Pfeffer M. Review of the current state of the art in heart failure. Heart failure. Lancet 2005;365:1877-1889.Прощаев К. И., Ильницкий А. Н., Постникова Л. И. и др. Клиническая патология полиморбидности в гериатрической практике. Успехи геронтологии 2011;2:285-9Прощаев К. И., Ильницкий А. Н., Постникова Л. И. и др. Клиническая патология полиморбидности в гериатрической практике. Успехи геронтологии 2011;2:285-9Лазебник Л. Б., Ефремов Л. И., Конев Ю. В. Семантические трудности при полиморбидности. Клиническая геронтология 2015;3-4:44-46Лазебник Л. Б., Ефремов Л. И., Конев Ю. В. Семантические трудности при полиморбидности. Клиническая геронтология 2015;3-4:44-46Braunstein J., Anderson G., Gerstenblith G. et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-1233Braunstein J., Anderson G., Gerstenblith G. et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-1233van Deursen V., Urso R., Laroche C. et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014;16:103-111van Deursen V., Urso R., Laroche C. et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014;16:103-111McMurray J., Adamopoulos S., Anker S. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J. Heart Fail 2012;14:803-869.McMurray J., Adamopoulos S., Anker S. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J. Heart Fail 2012;14:803-869.Altiparmak S., Altiparmak O. Drug-using behaviors of the elderly living in nursing homes and community-dwellings in Manisa, Turkey. Arch Gerontol Geriatr 2012;54: e242 - e248.Altiparmak S., Altiparmak O. Drug-using behaviors of the elderly living in nursing homes and community-dwellings in Manisa, Turkey. Arch Gerontol Geriatr 2012;54: e242 - e248.Lalic J., Radovanovic R., Mitic B. et al. Medication adherence in outpatients with arterial hypertension. Acta Facultatis Medicae Naissensis 2013;30 (4):209-218Lalic J., Radovanovic R., Mitic B. et al. Medication adherence in outpatients with arterial hypertension. Acta Facultatis Medicae Naissensis 2013;30 (4):209-218Кадыров Р. В., Асриян О. Б., Ковальчук С. А. Опросник «уровень комплаентности». Владивосток: Мор Гос Ун-т 2014; 74 с.Кадыров Р. В., Асриян О. Б., Ковальчук С. А. Опросник «уровень комплаентности». Владивосток: Мор Гос Ун-т 2014; 74 с.Molloy G., Perkins-Porras L., Bhattacharyya M. et al. Practical support predicts medication adherence and attendance at cardiac rehabilitation following acute coronary syndrome. J. Psychosom Res 2008;65 (6):581-586.Molloy G., Perkins-Porras L., Bhattacharyya M. et al. Practical support predicts medication adherence and attendance at cardiac rehabilitation following acute coronary syndrome. J. Psychosom Res 2008;65 (6):581-586.Yap A., Thirumoorthy T., Kwan Y. Medication adherence in the elderly. J. Clin Gerontol Geriatr 2016;2 (7):64-67.Yap A., Thirumoorthy T., Kwan Y. Medication adherence in the elderly. J. Clin Gerontol Geriatr 2016;2 (7):64-67.Yap A., Thirumoorthy T., Kwan Y. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int 2015. Oct 20. doi: 10.1111 /ggi.12616. [Epub ahead of print].Yap A., Thirumoorthy T., Kwan Y. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int 2015. Oct 20. doi: 10.1111 /ggi.12616. [Epub ahead of print].Чукаева И. И. Что такое приверженность к лечению и что можно сделать для ее улучшения (на примере артериальной гипертонии). Лечебное дело 2012;2:21-27Чукаева И. И. Что такое приверженность к лечению и что можно сделать для ее улучшения (на примере артериальной гипертонии). Лечебное дело 2012;2:21-27Ponikowski P., Voors A., Anker S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur HeartJ 2016; doi:10.1093/eur-heartj/ehw128.Ponikowski P., Voors A., Anker S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur HeartJ 2016; doi:10.1093/eur-heartj/ehw128.Mentz R., Kelly J., von Lueder T. et al. Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction. J. Am Coll Cardiol 2014;64 (21):2281-2293.Mentz R., Kelly J., von Lueder T. et al. Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction. J. Am Coll Cardiol 2014;64 (21):2281-2293.Chaudhry S., Wang Y., Gill T., Krumholz H. Geriatric conditions and subsequent mortality in older patients with heart failure. J. Am Coll Cardiol 2010;55:309-316.Chaudhry S., Wang Y., Gill T., Krumholz H. Geriatric conditions and subsequent mortality in older patients with heart failure. J. Am Coll Cardiol 2010;55:309-316.Dodson J., Chaudhry S. Geriatric conditions in heart failure. Curr Cardiovasc Risk Rep 2012;6 (5):404-410.Dodson J., Chaudhry S. Geriatric conditions in heart failure. Curr Cardiovasc Risk Rep 2012;6 (5):404-410.Santos-Eggimann B., Cuenoud P., Spagnoli J., Junod J. Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries. J. Gerontol A Biol Sci Med Sci 2009;64A (6):675-681.Santos-Eggimann B., Cuenoud P., Spagnoli J., Junod J. Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries. J. Gerontol A Biol Sci Med Sci 2009;64A (6):675-681.Stephen W., Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J. Nutr Health Aging 2009;5 (13):460-466.Stephen W., Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J. Nutr Health Aging 2009;5 (13):460-466.Beard J., Officer A., de Carvalho I. et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016;387:2145-54.Beard J., Officer A., de Carvalho I. et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016;387:2145-54.Fried L., Ferrucci L., Darer J. et al. Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care. J. Gerontology: Medical Sciences 2004;3 (59):255-263.Fried L., Ferrucci L., Darer J. et al. Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care. J. Gerontology: Medical Sciences 2004;3 (59):255-263.Vidan M., Sanchez E., Fernandez-Aviles F. et al. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics. Clin Cardiol 2014;37:725-732.Vidan M., Sanchez E., Fernandez-Aviles F. et al. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics. Clin Cardiol 2014;37:725-732.McLennan S., Pearson S., Cameron J., Stewart S. Prognostic importance of cognitive impairment in chronic heart failure patients: Does specialist management make a difference? Eur J. Heart Failure 2006;8:494-501.McLennan S., Pearson S., Cameron J., Stewart S. Prognostic importance of cognitive impairment in chronic heart failure patients: Does specialist management make a difference? Eur J. Heart Failure 2006;8:494-501.Halil M., Kizilarslanoglu M., Kuyumcu E. et al. Cognitive аspects of frailty: mechanisms behind the link between frailty and cognitive impairment. J. Nutr Health Aging 2015;19 (3):276-283.Halil M., Kizilarslanoglu M., Kuyumcu E. et al. Cognitive аspects of frailty: mechanisms behind the link between frailty and cognitive impairment. J. Nutr Health Aging 2015;19 (3):276-283.Vogels R., Scheltens P., Schroeder-Tanka J., Weinstein H. Cognitive impairment in heart failure: A systematic review of the literature. Eur J. Heart Fail 2007;5 (9):440-449.Vogels R., Scheltens P., Schroeder-Tanka J., Weinstein H. Cognitive impairment in heart failure: A systematic review of the literature. Eur J. Heart Fail 2007;5 (9):440-449.Fredericks S., Beanlands H., Spalding K., De Silva M. Effects of the characteristics of teaching on the outcomes of heart failure patients education interventions: A systematic review. Eur J. Cardiovasc Nursing 2010;9:30-37.Fredericks S., Beanlands H., Spalding K., De Silva M. Effects of the characteristics of teaching on the outcomes of heart failure patients education interventions: A systematic review. Eur J. Cardiovasc Nursing 2010;9:30-37.Störk S., Kavoliuniene A., Vinereanu D. et al. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J Heart Fail 2016;18:66-70Störk S., Kavoliuniene A., Vinereanu D. et al. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J Heart Fail 2016;18:66-70van der Wal M., Jaarsma T., Mose D. et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006;27:434-440van der Wal M., Jaarsma T., Mose D. et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006;27:434-440Мареев В. Ю., Беграмбекова Ю. Л., Даниелян М. О. и др. Какие вопросы задаются и на какие вопросы способны ответить исследования по немедикаментозному лечению пациентов с сердечной недостаточностью. Уроки исследования ШАНС. Сердечная недостаточность 2014; 15 (6):383-396Мареев В. Ю., Беграмбекова Ю. Л., Даниелян М. О. и др. Какие вопросы задаются и на какие вопросы способны ответить исследования по немедикаментозному лечению пациентов с сердечной недостаточностью. Уроки исследования ШАНС. Сердечная недостаточность 2014; 15 (6):383-396Luttik M., Jaarsma T., van Geel P. et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Failure 2014;16:1241-1248Luttik M., Jaarsma T., van Geel P. et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Failure 2014;16:1241-1248

The authors declare that there are no conflicts of interest present.